Dermatology

Latest News

australian health care and biosimilar | Image credit: Sandor Kacso - stock.adobe.com
Paving the Way for Equitable Biosimilar Access in Australian Dermatology Clinics

May 13th 2025

Australia’s growing reliance on high-cost biologics for inflammatory skin diseases has placed significant pressure on its health system—but a new report suggests biosimilars could offer financial relief, provided uptake barriers are addressed through policy reform and education.

pharmaceutical sales data | Image credit: N F/peopleimages.com - stock.adobe.com
Samsung Bioepis Report Signals Turning Point for US Biosimilars

May 1st 2025

patient talking to doctor |  Image credit: New Africa - stock.adobe.com
Clinical Evidence Shows No Safety Gaps Between Biosimilar, Reference Adalimumab

April 26th 2025

eye on pharma banner
Eye on Pharma: Sandoz Files Antitrust Suit; Yuflyma Interchangeability; Costco’s Ustekinumab Pick

April 22nd 2025

biosimilar business deal | Image credit: Mongkolchon - stock.adobe.com
Latest Biosimilar Deals Signal Growth Across Immunology, Oncology Markets

April 14th 2025

Video Interviews
Podcasts
CFB podcast banner
CFB
CFB podcast banner
CFB podcast banner
CFB podcast banner

More News

© 2025 MJH Life Sciences

All rights reserved.